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Summary 23 
Background: Biofilm has been suggested as a cause of disinfection failures in flexible 24 
endoscopes where no lapses in the decontamination procedure can be identified. To test 25 
this theory, the activity of peracetic acid (PAA), one of the commonly used disinfectants in 26 
the reprocessing of flexible endoscopes, was evaluated against both planktonic and sessile 27 
communities of Pseudomonas aeruginosa. 28 
Aim: To investigate the ability of P. aeruginosa biofilm to survive high level PAA disinfection. 29 
Method: The susceptibility of planktonic cells of P. aeruginosa and biofilms 24, 48, 96 and 30 
192 h old to PAA was evaluated by estimating their viability using resazurin viability and 31 
plate count methods. The biomass of the P. aeruginosa biofilms was also quantified using 32 
crystal violet assay. Planktonic cells of P. aeruginosa were treated with 5 – 30 ppm 33 
concentration of PAA in the presence of 3.0 g/L of Bovine serum albumin (BSA) for 5 min. 34 
Biofilms of P. aeruginosa were also treated with various PAA concentrations (100 - 3000 35 
ppm) for 5 min. 36 
Results:  Planktonic cells of P. aeruginosa were eradicated by 20 ppm of PAA, whereas 37 
biofilms showed an age dependent tolerance to PAA, and 96 h old biofilm was only 38 
eradicated at PAA concentration of 2500 ppm.  39 
Conclusion: 96 h old P. aeruginosa biofilm survives 5 min treatment with 2000 ppm of PAA, 40 
which is the working concentration used in some endoscope washer disinfectors. This 41 
implies that disinfection failure of flexible endoscopes could occur when biofilms are 42 
allowed to build up in the lumens of endoscopes.  43 
 44 
 45 
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Introduction 47 
High level disinfection (HLD) is used in the decontamination of heat sensitive medical 48 
equipment such as flexible endoscopes.(1) It entails the eradication of most microorganisms 49 
except for small numbers of bacterial spores and achieves a 6-log reduction of 50 
mycobacterium species. (2) This level of decontamination is acceptable for medical devices 51 
designated as semi-critical equipment, which according to the Spaulding classification, are 52 
devices that only touch the mucous membrane during use.(3, 4) Commonly used disinfectants 53 
for HLD include peracetic acid (PAA), glutaraldehyde, ortho-phthalaldehyde, chlorine dioxide 54 
and hydrogen peroxide with peracetic acid.(2, 5) Despite the efficacy of these biocides, there 55 
are reports of endoscope disinfection failure, where no clear lapses in the decontamination 56 
procedures can be identified; most of these involve duodenoscopes used for endoscopic 57 
retrograde cholangiopancreatography (ERCP) owing to their complex design.(6-9) Most 58 
endoscope disinfection failures are however due to lapses in the decontamination 59 
procedure, which may  allow biofilm formation in endoscope channels.(10, 11) Endoscope 60 
disinfection failure may also be due to the gradual accumulation of organic soils and wear 61 
on the surfaces of endoscope channels resulting in reduced exposure of bacteria to biocide 62 
and subsequent biofilm formation on endoscope channels.(10, 12, 13) There are evidences that 63 
bacterial species can form biofilm in endsocope lumens.(10, 14, 15) Biofilm formation can also 64 
occur within an endoscope reprocessor due to faults in it, or inadequate preventative 65 
maintenance for the unit. (14)  66 
Biofilm growth enhances the ability of bacteria to survive treatment with antimicrobial 67 
agents, due to a number of factors.(16-18) These include  reduced penetration of the agent  68 
into biofilms due to the presence of  extracellular matrix (ECM),  biofilm heterogeneity and 69 
biofilm specific phenotypes such as expression of efflux pump and persister cells. (19) 70 
Pseudomonas aeruginosa is one of the organism mostly associated with reported cases of 71 
endoscope contamination and endoscope associated infection.(20-22) Therefore P. aeruginosa 72 
was used as a model organism in this study.  PAA is an oxidising agent now commonly 73 
employed in the disinfection of endoscopes, with highly potent bactericidal and fungicidal 74 
activity at low concentrations. (23, 24)  In endoscope reprocessing, it is used at a concentration 75 
of 2000 to 3500 PPM depending on endoscope disinfection method and guidelines. PAA and 76 
other oxidising agents such as hydrogen peroxide have been increasingly adopted in 77 
endoscope disinfection due to hazards associated with glutaraldehyde based disinfectant 78 
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and emergence of glutaraldehyde resistant Mycobacterium species.(25)The aim of this study 79 
was to evaluate the efficacy of PAA against bacterial biofilms and examine the effect of 80 
biofilm maturity. We demonstrate that 96 hour  P. aeruginosa biofilms can survive 81 
treatment with the concentration of PAA currently used for endoscope disinfection. 82 
 83 
Material and Methods 84 
Inoculum preparation 85 
For each experiment, fresh overnight cultures of P. aeruginosa PA14 were prepared by 86 
inoculating a single colony of the isolates in Luria-bertani broth (Fluka, St. Louis USA) and 87 
incubated overnight at 37oC. Cells were recovered from the overnight culture through the 88 
centrifugation of 1 mL of the overnight culture at 10,000 x g for 5 min. The resulting pellets 89 
were re-suspended in 1 mL phosphate buffered saline (PBS) and washed twice by 90 
centrifugation at 10,000 x g for 5 min. The CFU of the inoculum for each experiment was 91 
standardised using their OD570nm absorbance.  92 
 93 
Neutraliser validation  94 
A neutraliser solution containing 1.0 % w/v sodium thiosulphate pentahydrate (ACROS 95 
Organics, Loughborough UK), 0.5 % w/v sodium dodecyl sulphate (BDH Laboratory Supplies, 96 
poole UK), 1.0 % w/v granular lecithin (ACROS Organics New Jersey US), 15 % w/v of 97 
Polysorbate 80 (ACROS Organics Loughborough UK) and 0.1 % w/v L-Histidine (ACROS 98 
Organics New Jersey US) was prepared and sterilised by membrane filtration. Efficacy and 99 
toxicity of the neutraliser against P. aeruginosa PA14 was evaluated using a suspension 100 
challenge method as specified in BS EN 13727 2012+A1 2013.(26) 101 
 102 
Biofilm formation 103 
Biofilms were prepared in 24-well plates (CellBIND Clear polystyrene Corning). Briefly, P. 104 
aeruginosa PA14 cells were recovered from overnight culture as highlighted above. 105 
Adjusted cultures were serially diluted in LB broth to obtain a final bacterial concentration 106 
of ≈1 x 106 CFU/ml. Wells of the 24-well plate ware inoculate with 1 mL of diluted inoculum 107 
for biofilm formation. Plates were incubated at 37oC for 24, 48, 96 and 192 h, as 108 
appropriate, with spent media aseptically replaced every 24 h.  109 
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 110 
 111 
Peracetic acid treatment  112 
The susceptibility of P. aeruginosa PA14 planktonic cells to PAA was evaluated according to 113 
the suspension challenge method with slight modifications.(26) The P. aeruginosa cell 114 
suspension was prepared by adding 0.1 ml of cell suspension in PBS prepared as described 115 
above to 0.9 mL of different concentrations of PAA (5 – 30 PPM), containing 3.0 g/L of BSA 116 
(mimicking dirty soiling condition) to obtain ≈1 x 108 CFU/mL of bacteria in the final 117 
suspension. After 5 min exposure time, PAA activity was quenched by adding neutraliser to 118 
treated cells for 10 min. Preliminary experiments (data not shown) showed that the 119 
neutraliser used in this study (1.0 % w/v sodium thiosulphate pentahydrate, 0.5 % w/v 120 
sodium dodecyl sulphate, 1.0 % w/v granular lecithin, 15 % w/v of Polysorbate 80 and 0.1 % 121 
w/v L-Histidine) is effective in neutralising the activity of PAA and not toxic to P. aeruginosa. 122 
For the biofilm assay, biofilms were treated with 1.5 mL of PAA (100 - 3000 PPM) diluted in 123 
sterile distilled water for 5 min, then subsequently neutralised for 10 min. The viability of 124 
the treated cells was evaluated either through the evaluation of their metabolic activity 125 
using the resazurin dye assay or plate count evaluation of cell viability.  126 
 127 
Alamar blue resazurin evaluation of metabolic activity 128 
For the resazurin assay, 1 mL of 10% Alamar blue (Invitrogen, Frederick, MD) diluted in LB 129 
broth was added to treated cells and incubated in the dark at 37oC with a negative control 130 
of 10% alamar blue in LB broth. Based on preliminary optimisation experiments (data not 131 
shown), after 6 h of incubation, 100 µL of the 10% alamar blue dye was transferred to 96 132 
well flat bottom plates. The absorbance of the dye was taken at 570 and 595nm using 96 133 
well plate reader (Tecan Infinite F200 PRO). Percentage cell viability was calculated using a 134 
viability formula.(27) 135 
 136 
Plate count evaluation of colony forming unit (CFU)  137 
The drop plate technique was also used to evaluate the viability of the treated cells on LB 138 
agar.(28) 20 µL of serially diluted treated cells re-suspended in 1 mL of PBS were transferred 139 
to LB agar plates in triplicates. Plates were allowed to dry at room temperature and 140 
subsequently incubated at 37oC. After 24 h of incubation, colonies on plates were counted 141 
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and CFU/well of the surviving cells were calculated. For the biofilm experiment, biofilms 142 
were scraped into 1 mL of PBS in micro-centrifuge tubes and disrupted in a water bath 143 
sonicator (Fisherbrand FB11201) at 37 KHz for 5 min.(29) Sonicated biofilm were vortexed for 144 
30 s, prior to serial dilution and viability evaluated using the drop plate technique. 145 
 146 
Quantification of bacterial biofilm biomass 147 
The total biomass of 24, 48, 96 and 192 h old P. aeruginosa PA14 biofilms was quantified 148 
using a crystal violet assay with slight modifications.(30) Biofilms were grown for 24, 48, 96 or 149 
192 h in 24-well plates as previously described. Biofilms were washed with PBS after the 150 
removal of growth media. 1 ml of 0.1% w/v crystal violet was added and plates incubated 151 
for 30 min at room temperature. Crystal violet was subsequently removed and biofilm 152 
washed with sterile distilled water. Crystal violet remnant binding to the biofilm biomass 153 
was dissolved in 1 mL 95% ethanol for 30 min. The absorbance (570nm) of the dissolved 154 
crystal violet was measured in a 96 well plate reader (Tecan Infinite F200 PRO) using 100 µl 155 
of dissolved crystal violet.  156 
 157 
Statistical analysis 158 
All data are presented as mean of three independent replicates ±SD. One way ANOVA was 159 
used for statistical analysis using the Graphpad prism 6 with P < 0.05 considered as 160 
statistically significant. 161 
 162 
Results 163 
PAA was very active against planktonic cells of P. aeruginosa at the soiling condition used 164 
for this study. Planktonic cells were killed at a concentration of 20 ppm after 5 min of 165 
exposure to PAA (Figure 1). For the planktonic study both cell viability resazurin evaluation 166 
of cell viability and the plate count study showed similar results. Initial experiments to 167 
evaluate the susceptibility of biofilm of various ages to PAA concentration ranging from 100 168 
- 800 PPM showed that biofilm mediate more than a 100-fold increase in minimum 169 
eradication concentration of PAA against P. aeruginosa which increase with biofilm age. The 170 
minimum concentrations of PAA which killed 24 h and 48 h biofilm were 400 and 800 PPM 171 
respectively (Figure 2). However, 800 PPM of PAA which is the highest concentration used 172 
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for the initial biofilm experiment only achieved a 1 log10 reduction in the CFU of 96 and 192 173 
h biofilms as shown in Figure 2B. For the aged biofilm experiment, there was no good 174 
correlation between cell viability resazurin and the plate count assay. The cell viability 175 
resazurin assay for instance showed about 95% and 60% loss in viability of 96 and 192 h 176 
biofilms, respectively, treated with 800 PPM of PAA. By contrast,, only a 1 log10 reduction in 177 
CFU of the treated biofilm was estimated by the plate count assay, as summarised in Figure 178 
2.   Further experiments with concentrations of PAA up to 3000 PPM showed that 96 h 179 
biofilms retained viability as assessed by plate count assay at 2000 PPM, but were killed at 180 
2500 ppm (Figure 3).  181 
To evaluate the contribution of biofilm biomass to age associated biofilm tolerance to PAA, 182 
the biomass of 24, 48, 96 and 192 h old biofilm was evaluated using the crystal violet 183 
quantification assay. Biofilm biomass increased significantly with age from 24 to 192 h (P < 184 
0.001). Despite the wide difference in concentration of PAA needed to kill 48 and 96 h old 185 
biofilms, there was no significant difference in their biomass quantified using the crystal 186 
violet assay (Figure 4). 187 
 188 
 189 
Discussion and Conclusion 190 
Biofilm associated reduced bacterial susceptibility to disinfectants has been reported(29, 31) 191 
but exact mechanisms of this resistance remain to be elucidated. Unlike antibiotics, which 192 
often target specific bacterial pathways, disinfectants have non-specific activity and target 193 
multiple cellular components or metabolic pathways simultaneously. (32) This has led to a 194 
relaxed attitude to potential disinfectant resistance as it is assumed that the recommended 195 
concentration of disinfectants is always well above the level required to kill the target 196 
organism. However, this thinking ignores the potential effects of the biofilm phenotype. 197 
High level disinfectants such as PAA used in the reprocessing of semi-critical medical 198 
equipment are active against vegetative bacteria, mycobacteria, bacterial spores, fungi and 199 
viruses.(2) However, the presence of organic debris and biofilm extracellular matrix (ECM) 200 
can significantly reduce the activity of disinfectant underlining the importance of the 201 
physical cleaning step prior to disinfection.(33) Here we have shown that the biofilm 202 
phenotype mediates a 100-fold increase in the minimum eradication concentration of PAA 203 
against P. aeruginosa biofilms bringing the concentration needed to kill the organism to the 204 
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working concentration of the disinfectant (which ranges between 2000 and 3500 PPM 205 
depending on the reprocessing procedure). Reduced biofilm susceptibility to PAA in other 206 
bacterial species have also been shown (17, 34, 35), and previous studies have compared the 207 
susceptibility of the planktonic form of these  bacteria and their biofilm phenotype 208 
reporting similar or even higher susceptibility of biofilm bacteria to PAA. (36, 37) However, 209 
these studies did not consider the reactivity of PAA with culture media used in the 210 
planktonic experiments.  211 
We have found that the concentration of PAA required to eradicate P. aeruginosa biofilm is 212 
dependent upon the age of the biofilm. A similar observation has been reported by Cabeca 213 
et al, who tested benzalkonium chloride against Staphylococcus aureus biofilm. Age related 214 
resistance to glutaraldehyde, ahigh level disinfectant also used in endoscope disinfection, 215 
has been reported in P. aeruginosa and P. flourescens. (38) Resistance to disinfection may be 216 
due to the components of the ECM, which react with the disinfectant before the agent 217 
reaches the bacterial cell surface. If this is the case then higher biomass should result in 218 
reduced effectiveness of disinfection. However, we have shown that the difference in 219 
biomass between the 48 h and 96 h old biofilms is not significant compared with the 220 
difference between 24 h and 48 h biofilms, yet there is a wider difference in the 221 
susceptibility of 48 h and 96 h biofilm to PAA, suggesting that other biofilm associated 222 
mechanisms cannot be ruled out.  223 
In conclusion, our study shows that mature biofilms may not be killed by currently 224 
recommended concentrations of PAA. However, for this to occur bacterial contaminants 225 
must be left to mature into biofilms for prolonged periods, 96 h in our system. In practical 226 
terms this would be any organisms left in endoscope channels for prolonged periods, for 227 
example biofilm build-up in endoscope channels due to endoscope reprocessing failure 228 
lasting for days before detection and subsequent rectification. However, if disinfection 229 
occurs daily biofilms sufficiently mature to cause problems with currently used 230 
concentrations disinfectants should not occur. To this end, periodic microbiological 231 
monitoring of endoscope as prescribed by some guidelines should be encouraged as a 232 
control measure in endoscope reprocessing. (39, 40) However a sampling and detection 233 
method that can detect possible microbial biofilm build up in endoscope lumen should be 234 
employed. Likewise regular servicing of endoscopes to avoid biofilm build up should be 235 
encouraged. This study examined the susceptibility of biofilm grown in multiple well plates 236 
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using LB replaced daily. However, biofilm build-up in endoscopes occurs under more 237 
stringent conditions; this study therefore depicts a worst case scenario on biofilm in 238 
endoscopes.  239 
  240 
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1 347 
 348 
Experiments  Log10(CFU) 
 
Efficacy test 
Initial Inoculum 2.91 ± 0.14  
Testa 2.82 ± 0.06 
Controlb 0.00  
Toxicity test Initial Inoculum 3.76 ± 0.13 
Testc 3.93 ± 0.19 
 349 
a
inoculum exposed to neutralised 4000 PPM PAA,  
b
inoculum exposed to unneutralised 4000 350 
PPM PAA,  
c
inoculum exposed to nuetralisation mixture  351 
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Legends 381 
Table 1: Evaluation of the efficacy and toxicity of Peracetic acid neutraliser 382 
 383 
Figure 1: PAA is very active in killing planktonic cells of P. aeruginosa in the presence of 3.0 g/L of 384 
BSA mimicking high soiling condition. Evaluation of PAA activity against planktonic cells measured by 385 
the resazurin viability assay (A) and the conventional plate count techniques (B) showed good 386 
correlation.  Graph show the mean data from independent triplicate experiment ± SD. 387 
 388 
Figure 2: P. aeruginosa biofilm demonstrated an age dependent tolerance to PAA. The evaluation of 389 
biofilm susceptibility to PAA using the resazurin viability assay (A) and the conventional plate count 390 
technique (B) showed better correlation for young biofilms (24 and 48 hs old) compared to the old 391 
biofilm (96 and 192 hs old). The highest concentration of PAA used in this study can only achieve a 392 
log reduction in the CFU of aged biofilms. Data is a mean of independent triplicate experiments ±SD. 393 
 394 
Figure 3: 96 hs old biofilm is eradicated at 2500 ppm of PAA after 5 minutes’ exposure.  Biofilm 395 
viability after PAA treatment was evaluated by the plate count technique.  Graph shown represents 396 
the mean of data from three independent replicates with error bar showing ±SD. 397 
 398 
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Figure 4: Biofilm biomass as evaluated by the crystal violet assay increase with biofilm age. 399 
There ws significant increase in biomass from 24 to 48, 96 and 192 hs (***P value <0.001) as 400 
well as between the 48 and 192 Hs old biofilm (**Pvalue <0.01). Graph is showing the 401 
average of data from indipendent triplicate experiment ±SD  402 
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